Nicotine in therapeutic angiogenesis and vasculogenesis
US7160904B2 · kind B2 · utility
2Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2002 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Jan 3, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods for induction of angiogenesis by administration of nicotine or other nicotine receptor agonist. Induction of angiogenesis by the methods of the invention can be used in therapeutic angiogenesis in, for example, treatment of ischemic syndromes such as coronary or peripheral arterial disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.